Lara Meisner is Chief Legal Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 29,971 shares of VRDN, which is worth approximately $593,126. The most recent transaction as insider was on Jun 16, 2023, when has been sold 27 shares (Common Stock) at a price of $28.35 per share, resulting in proceeds of $765. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
0% 12M change
Total Value Held $593,126

Lara Meisner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Open market or private sale
$765 $28.35 p/Share
27 Reduced 0.09%
29,971 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
$621 $23.03 p/Share
27 Added 0.09%
29,998 Common Stock
Jun 15 2023
SELL
Open market or private sale
$63,577 $28.02 p/Share
2,269 Reduced 7.04%
29,971 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
$52,255 $23.03 p/Share
2,269 Added 6.58%
32,240 Common Stock
Jun 06 2023
SELL
Open market or private sale
$128,252 $25.02 p/Share
5,126 Reduced 14.61%
29,971 Common Stock
Jun 06 2023
BUY
Exercise of conversion of derivative security
$94,882 $18.51 p/Share
5,126 Added 12.74%
35,097 Common Stock
Jun 05 2023
SELL
Open market or private sale
$12,489 $25.03 p/Share
499 Reduced 1.64%
29,971 Common Stock
Jun 05 2023
BUY
Exercise of conversion of derivative security
$9,236 $18.51 p/Share
499 Added 1.61%
30,470 Common Stock
Jun 02 2023
SELL
Open market or private sale
$45,393 $24.21 p/Share
1,875 Reduced 5.89%
29,971 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
$26,250 $14.0 p/Share
1,875 Added 5.56%
31,846 Common Stock
Mar 09 2023
SELL
Open market or private sale
$871,256 $29.07 p/Share
29,971 Reduced 100.0%
0 Common Stock
Jan 23 2023
SELL
Open market or private sale
$244,021 $35.66 p/Share
6,843 Reduced 100.0%
0 Common Stock
Jan 23 2023
BUY
Exercise of conversion of derivative security
$126,732 $18.52 p/Share
6,843 Added 50.0%
6,843 Common Stock
Dec 21 2022
SELL
Open market or private sale
$476,555 $29.19 p/Share
16,326 Reduced 100.0%
0 Common Stock
Dec 21 2022
BUY
Exercise of conversion of derivative security
$375,987 $23.03 p/Share
16,326 Added 50.0%
16,326 Common Stock
Dec 20 2022
SELL
Open market or private sale
$16,842 $28.07 p/Share
600 Reduced 100.0%
0 Common Stock
Dec 20 2022
BUY
Exercise of conversion of derivative security
$13,818 $23.03 p/Share
600 Added 50.0%
600 Common Stock
Dec 16 2022
SELL
Open market or private sale
$36,886 $28.44 p/Share
1,297 Reduced 100.0%
0 Common Stock
Dec 16 2022
BUY
Exercise of conversion of derivative security
$29,869 $23.03 p/Share
1,297 Added 50.0%
1,297 Common Stock
Dec 15 2022
SELL
Open market or private sale
$8,424 $28.08 p/Share
300 Reduced 100.0%
0 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$6,909 $23.03 p/Share
300 Added 50.0%
300 Common Stock
Dec 14 2022
SELL
Open market or private sale
$440,246 $28.12 p/Share
15,656 Reduced 100.0%
0 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$360,557 $23.03 p/Share
15,656 Added 50.0%
15,656 Common Stock
Dec 12 2022
SELL
Open market or private sale
$16,830 $28.05 p/Share
600 Reduced 100.0%
0 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$13,818 $23.03 p/Share
600 Added 50.0%
600 Common Stock
LM

Lara Meisner

Chief Legal Officer
Waltham, MA

Track Institutional and Insider Activities on VRDN

Follow Viridian Therapeutics, Inc.\DE and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

News

Receive news related to Viridian Therapeutics, Inc.\DE

Track Activities on VRDN